| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7de02e4b28736bfb52de8bb358be203e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 |
| filingDate |
1978-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
1980-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9c61682350a33e3983f6fb74b7f1c602 |
| publicationDate |
1980-03-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-4191753-A |
| titleOfInvention |
Anti-hypertensive peptide analogs |
| abstract |
Novel peptides having the sequence <Glu-Trp-A3-Arg-A5-Gln-Ile-A8-A9 wherein A3, A5, A8 and A9 are either L-proline or L-3,4-dehydroproline, are disclosed. These peptides are potent inhibitors of angiotensin converting enzyme and are useful as antihypertensive agents. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4804743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005031604-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4293481-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6911431-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9619491-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5902790-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6096713-A |
| priorityDate |
1978-11-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |